Pfizer PFE Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Pfizer in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The official record: Pfizer’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pfizer's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Pfizer's accounts payable?
- Pfizer (PFE) reported accounts payable of $4.51B in Q1 2026.
- How has Pfizer's accounts payable changed year-over-year?
- Pfizer's accounts payable decreased by 14.0% year-over-year, from $5.24B to $4.51B.
- What is the long-term trend for Pfizer's accounts payable?
- Over 5 years (2020 to 2025), Pfizer's accounts payable has grown at a 4.1% compound annual growth rate (CAGR), from $4.28B to $5.24B.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.